Evidence map›Paper›PMID 27390286›Full record

ArticleAdvanced healthcare materials2016

Pilot Mouse Study of 1 mm Inner Diameter (ID) Vascular Graft Using Electrospun Poly(ester urea) Nanofibers.

Yaohua Gao, Tai Yi, Toshiharu Shinoka, Yong Ung Lee, Darrell H Reneker, Christopher K Breuer, Matthew L Becker

Open access · greenAbstract read
In one paragraph

Article in Advanced healthcare materials, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
2.5field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 36 citations in OpenAlex.

  1. Article
  2. Article
  3. Micro- and nanoscale biophysical cues for cardiovascular disease therapy.Nanomedicine : nanotechnology, biology, and medicine · 2021
    Review
  4. Article
  5. Mouse Model of Tracheal Replacement With Electrospun Nanofiber Scaffolds.The Annals of otology, rhinology, and laryngology · 2019
    Article
  6. Implantation of VEGF-functionalized cell-free vascular grafts: regenerative and immunological response.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2019
    Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Yaohua GaoDepartment of Polymer Science, The University of Akron, Akron, OH, 44325, USA.
Tai YiDepartment of Surgery, Nationwide Children's Hospital, Columbus, OH, 43205, USA.
Toshiharu ShinokaDepartment of Surgery, Nationwide Children's Hospital, Columbus, OH, 43205, USA.
Yong Ung LeeDepartment of Surgery, Nationwide Children's Hospital, Columbus, OH, 43205, USA.
Darrell H RenekerDepartment of Polymer Science, The University of Akron, Akron, OH, 44325, USA.
Christopher K BreuerDepartment of Surgery, Nationwide Children's Hospital, Columbus, OH, 43205, USA.
Matthew L BeckerDepartment of Polymer Science, The University of Akron, Akron, OH, 44325, USA. becker@uakron.edu.
Nationwide Children's Hospital · USUniversity of Akron · US

Funding

Mechanisms of Vascular Neotissue Formation In Tissue Engineered Vascular GraftsR01HL098228 · NHLBI · YALE UNIVERSITY · PI BREUER, CHRISTOPHER KANE · 2010 to 2018
$3.6M
NHLBI NIH HHS R01 HL098228
6 · The paper itself

Abstract

An off-the-shelf, small diameter tissue engineered vascular graft (TEVG) would be transformative to surgeons in multiple subspecialties. Herein, the results of a small diameter (ID ≈ 1 mm) vascular graft constructed from resorbable, amino acid-based poly(ester urea) (PEU) are reported. Electrospun PEU grafts of two different wall thicknesses (type A: 250 μm; type B: 350 μm) are implanted as abdominal infra-renal aortic grafts in a severe combined immune deficient/beige mouse model and evaluated for vessel remodeling over one year. Significantly, the small diameter TEVG does not rupture or lead to acute thrombogenic events during the intervals tested. The pilot TEVG in vivo shows long-term patency and extensive tissue remodeling with type A grafts. Extensive tissue remodeling in type A grafts leads to the development of well-circumscribed neovessels with an endothelial inner lining, a neointima containing smooth muscle cells. However, due to slow degradation of the PEU scaffold materials in vivo, the grafts remain after one year. The type B grafts, which have 350 μm thick walls, experience occlusion over the one year interval due to intimal hyperplasia. This study affords significant findings that will guide the design of future generations of small diameter vascular grafts.

Indexed as

Aorta, AbdominalBioprosthesisBlood Vessel ProsthesisBlood Vessel Prosthesis ImplantationMaterials TestingNeointimaAnimalsFemaleHumansHuman Umbilical Vein Endothelial CellsMiceMice, SCIDPilot ProjectsPolyestersTissue ScaffoldsUreaPolyesterspoly(ester-urea)Ureabioresorbableelectrospun scaffoldspoly(ester urea)SCID/Bg micesmall diameter TEVG

Identifiers

PMID27390286
PMCPMC5951289
OpenAlexW2463415830

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.